How likely are you to benefit from chemotherapy? This short video can help prepare for your appointment with your doctor to review your Breast Recurrence Score® results.
Your Breast Recurrence Score results
Your results will be available to your doctor about 2 weeks after your tumor sample arrives at the Exact Sciences lab.* The results provide a Recurrence Score® result between 0 and 100 that says how likely your cancer is to return and predicts how much chemotherapy will help you.
A low Recurrence Score result means the cancer has a lower chance of returning and you have a lower chance of benefiting from chemotherapy
A high Recurrence Score result means the cancer has a higher chance of returning and you have a higher chance of benefiting from chemotherapy
For example, patients with a high Recurrence Score result often choose more aggressive treatment options, including chemotherapy, than patients with low scores. It is important to understand that a low Recurrence Score result does not mean there is no chance that your breast cancer will return. And a high Recurrence Score result does not mean that your breast cancer will definitely return. So, your treatment decisions still depend on your unique situation and personal preferences.
“When I learned my Recurrence Score it brought me instant relief that I was not going to have to do chemotherapy.”
Shelly W., breast cancer survivor and Oncotype DX Ambassador
Recurrence Score® result: 17
“The Recurrence Score test provided me assurance that I needed chemotherapy. I want to share my story to make sure patients hear both sides of the experience.”
Ellie T., breast cancer survivor and Oncotype DX Ambassador
Recurrence Score® result: 31
85%
of Breast Recurrence Score test patients have $0 financial responsibility*
This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Patient cost-sharing amounts, including deductibles and copays, will vary by plan and coverage type. Only your insurer can confirm if and how Breast Recurrence Score test will be covered.
90%
of Breast Recurrence Score test patients have a financial responsibility of <$100*
This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Patients with high-deductible plans may receive a bill for most or all the cost of the Breast Recurrence Score test if they have not satisfied their deductible.